Genpact Announces Pricing of Upsized Secondary Offering on Behalf of Selling Shareholders

NEW YORK--()--Genpact Limited (NYSE: G), a leader in managing business processes, today announced the pricing of an underwritten secondary public offering of 33.6 million common shares at a public offering price of $15.00 per share. The size of the offering was increased from the previously announced 28 million common shares. The shares are being sold by certain shareholders, consisting of affiliates of the General Electric Company, General Atlantic LLC, Oak Hill Capital Partners and Wells Fargo & Company. In connection with the offering, certain of the selling shareholders have granted to the underwriters an option to purchase up to 5.04 million additional shares. The offering is expected to close on March 24, 2010, subject to customary closing conditions.

Genpact will not receive any proceeds from the offering.

Morgan Stanley & Co. Incorporated, Goldman, Sachs & Co., Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC and UBS Securities LLC are serving as joint book-running managers. J.P. Morgan Securities Inc. and Wells Fargo Securities, LLC are serving as co-lead managers.

A shelf registration statement relating to the offering of the common shares has previously been filed with the U.S. Securities and Exchange Commission and has become effective. The offer is being made by the selling shareholders only by means of a prospectus supplement and accompanying prospectus, forming an effective part of the registration statement. Before investing, you should read the prospectus supplement and the accompanying prospectus for information about Genpact Limited, the selling shareholders and this offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. A copy of the prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated, 180 Varick Street, 2nd Floor, New York, New York 10014, Attention: Prospectus Department, or by calling (866) 718-1649 or by emailing prospectus@morganstanley.com, and from Goldman, Sachs & Co., Prospectus Department, 85 Broad Street, New York, NY 10004, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.

About Genpact

Genpact is a leader in managing business processes, offering a broad portfolio of enterprise and industry-specific services. The company manages over 3,000 processes for more than 400 clients worldwide. Putting process in the forefront, Genpact couples its deep process knowledge and insights with focused IT capabilities, targeted analytics and pragmatic reengineering to deliver comprehensive solutions for clients. Lean and Six Sigma are an integral part of Genpact’s culture and Genpact views the management of business processes as a science. Genpact has developed Smart Enterprise Processes (SEPSM), a groundbreaking, rigorously scientific methodology for managing business processes, which focuses on optimizing process effectiveness in addition to efficiency to deliver superior business outcomes. Services are seamlessly delivered from a global network of centers to meet a client’s business objectives, cultural and language needs and cost reduction goals.

Contacts

Investors
Genpact Limited
Shishir Verma, +1 646-624-5912
shishir.verma@genpact.com
or
Media
Kelli Gail (For Genpact - US)
+1 212-880-5261
Kelli.gail@ogilvypr.com

Recent Stories from Genpact Limited

RSS feed for Genpact Limited